Faircraft and BSF Enterprise drive innovation in sustainable lab-grown leather
Faircraft, a French biotech start-up, has secured $15.8 million to scale lab-grown leather production. Learn about their sustainable innovation here.
Faircraft, a French biotech start-up, has secured $15.8 million to scale lab-grown leather production. Learn about their sustainable innovation here.
As COP 29 unfolds, there is growing hope that cultivated meat may finally gain the essential financial and regulatory support needed to achieve scalability and commercial success. Che Connon, managing
Kerato’s innovative “biosynthetic cornea” provides a promising alternative to traditional donor corneal transplants. Designed for one-time use, this injectable device is administered single-handedly. It forms a self-sealing gel in the
BSF Enterprise Plc (LON:BSFA), the parent to a portfolio of innovative subsidiary companies developing cell-based tissue engineering solutions to deliver sustainable outcomes across a variety of sectors, has provided the following
BSF Enterprise, along with its subsidiaries, has recently achieved ISO 9001 certification, a globally recognised standard for quality management systems. This accomplishment signifies a strong commitment to quality across all
CytoBoost is a new, premium approach to cell culture, offering laboratories a way to enhance the health and performance of their cells. With this innovative product, you can think of
BSF Enterprise plc, a UK-based biotechnology investment company, has been at the forefront of sustainable innovation, especially through its subsidiary, Lab-Grown Leather. Managing Director Dr. Che Connon recently discussed how
Europe’s approach to the agri-tech revolution is increasingly viewed as outdated, with its regulations often criticised as overly protectionist and wary of technological advancements. The continent’s approach to cell-grown meat
The aging global population is driving a rise in vision impairment, which in turn affects physical, cognitive, and mental health. Among the most commonly transplanted human tissues worldwide are corneas,
A UK-based biotech company recently achieved a significant milestone by producing a larger size of cultivated skin tissue at its laboratory in Newcastle. The company, Lab-Grown Leather (LGL), formerly known